OverviewYorvipath is a hormone replacement medicine for treating adults with chronic hypoparathyroidism.In patients with this condition, the parathyroid glands in the neck do...
OverviewZimbus Breezhaler is an asthma medicine for inhalation. It is used for maintenance (regular) treatment in adults whose asthma is not controlled well...
OverviewDynastat is a painkilling medicine for use in adults for the short-term relief of pain after an operation.It contains the active substance parecoxib.Expand...
OverviewThis is a summary of the European public assessment report (EPAR) for Hexacima. It explains how the Agency assessed the medicine to recommend...
OverviewTarceva is a cancer medicine used in non‑small-cell lung cancer (NSCLC) that is advanced (the cancer has started to spread) or metastatic (it...
OverviewCoagadex is a medicine used for the treatment and prevention of bleeding (including during and after an operation) in patients with hereditary factor...
OverviewThis is a summary of the European public assessment report (EPAR) for Ibandronic acid Accord. It explains how the Agency assessed the medicine...
OverviewThis is a summary of the European public assessment report (EPAR) for Viagra. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Mirvaso. It explains how the Agency assessed the medicine to recommend...
OverviewThis is a summary of the European public assessment report (EPAR) for Xoterna Breezhaler. It explains how the European Medicines Agency assessed the...
OverviewVegzelma is a cancer medicine used to treat adults with the following types of cancer, in combination with other cancer medicines:cancer of the...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
The European Medicines Agency (EMA) makes upgrades to this website from time to time, to improve user experience. During these upgrades, the website...